Scripps Research launches DETECT study, leveraging wearable data to flag viral illnesses

LA JOLLA, CA — The Scripps Research Translational Institute has launched an app-based research program that will analyze participants’ wearable health data–including heart rates, sleep and activity levels–to more quickly detect the emergence of influenza, coronavirus and other fast-spreading viral illnesses. Members of the public who are 18 or older and use a smartwatch or…

Culturally adapted materials boost Latino participation in diabetes education programs

CORVALLIS, Ore. — An Oregon State University study published last week found that diabetes education programs that are linguistically and culturally tailored to Latinos lead to significantly higher rates of completion among Latino participants — even higher than rates among non-Latinos enrolled in the English versions of those programs. Cultural adaptation means that a program…

Trastuzumab deruxtecan shows early promise in patients with non-breast/gastric cancers

Bottom Line: A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric cancer types, according to results from a phase I study. Journal in Which the Study was Published: Cancer Discovery, a journal of the American Association for Cancer Research Author: Lead author: Junji Tsurutani, MD, PhD, medical oncologist at…